Skip to content

Jean Jacques Bienaime, Director at Ascendis Pharma A/S, bought ASND on Aug 14, 2026

Data as of Oct 16

▲ BUY$270K1,100 shares at $245.85Jean Jacques Bienaime DirectorASND Ascendis Pharma A/S
Watch ASND
Traded
Aug 14, 2026
Disclosed
Aug 18, 2026
Filed
4 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Jean Jacques Bienaime, Director at Ascendis Pharma A/S, bought ASND on Aug 14, 2026TRADEDDISCLOSED
ASNDSimilar stocks (XLV — its sector index fund), rebased to ASND's price on the disclosure day
ASND since disclosure
−9.5%
Similar stocks (XLV) since disclosure
+4.1%
XLV — its sector index fund

Change in closing price from Aug 18, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▲ BUYJean Jacques Bienaime DirectorASND Ascendis Pharma A/S$222Kdisclosed Aug 18 · filed 4 days after the trade

See every trade on ASND →